| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nuclear steroid receptor activity | 1.05e-08 | 25 | 60 | 5 | GO:0003707 | |
| GeneOntologyMolecularFunction | retinoic acid-responsive element binding | 8.95e-07 | 7 | 60 | 3 | GO:0044323 | |
| GeneOntologyMolecularFunction | nuclear receptor activity | 9.94e-07 | 60 | 60 | 5 | GO:0004879 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 1.05e-06 | 26 | 60 | 4 | GO:0005248 | |
| GeneOntologyMolecularFunction | ligand-activated transcription factor activity | 1.08e-06 | 61 | 60 | 5 | GO:0098531 | |
| GeneOntologyMolecularFunction | sodium ion binding | 9.17e-06 | 14 | 60 | 3 | GO:0031402 | |
| GeneOntologyMolecularFunction | sodium channel activity | 1.79e-05 | 52 | 60 | 4 | GO:0005272 | |
| GeneOntologyMolecularFunction | nuclear vitamin D receptor binding | 2.04e-05 | 18 | 60 | 3 | GO:0042809 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 6.38e-05 | 26 | 60 | 3 | GO:0031420 | |
| GeneOntologyMolecularFunction | nuclear thyroid hormone receptor binding | 1.44e-04 | 34 | 60 | 3 | GO:0046966 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 1.53e-04 | 664 | 60 | 9 | GO:0008324 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.62e-04 | 171 | 60 | 5 | GO:0015081 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 5.64e-04 | 343 | 60 | 6 | GO:0005261 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 5.64e-04 | 793 | 60 | 9 | GO:0015075 | |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 8.20e-04 | 61 | 60 | 3 | GO:0030374 | |
| GeneOntologyMolecularFunction | acetylcholine-gated monoatomic cation-selective channel activity | 1.17e-03 | 17 | 60 | 2 | GO:0022848 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 1.17e-03 | 17 | 60 | 2 | GO:0099508 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein serine/threonine kinase activity | 1.63e-03 | 20 | 60 | 2 | GO:0004675 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 2.14e-03 | 85 | 60 | 3 | GO:0019199 | |
| GeneOntologyMolecularFunction | acetylcholine receptor activity | 2.16e-03 | 23 | 60 | 2 | GO:0015464 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 2.50e-03 | 459 | 60 | 6 | GO:0005216 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SCN1A SCN2A SCN3A SLC9B2 SLC47A1 ABCA7 CHRNA5 SLC2A4 CHRNG TPCN1 | 2.53e-03 | 1180 | 60 | 10 | GO:0022857 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 2.66e-03 | 627 | 60 | 7 | GO:0022890 | |
| GeneOntologyMolecularFunction | gated channel activity | 3.27e-03 | 334 | 60 | 5 | GO:0022836 | |
| GeneOntologyMolecularFunction | transporter activity | SCN1A SCN2A SCN3A SLC9B2 SLC47A1 ABCA7 CHRNA5 SLC2A4 CHRNG TPCN1 | 4.75e-03 | 1289 | 60 | 10 | GO:0005215 |
| GeneOntologyMolecularFunction | channel activity | 4.84e-03 | 525 | 60 | 6 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 4.88e-03 | 526 | 60 | 6 | GO:0022803 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 2.48e-05 | 121 | 59 | 5 | GO:0051899 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 3.17e-05 | 63 | 59 | 4 | GO:0019228 | |
| GeneOntologyBiologicalProcess | steroid hormone receptor signaling pathway | 8.11e-05 | 155 | 59 | 5 | GO:0043401 | |
| GeneOntologyBiologicalProcess | positive regulation of vitamin D receptor signaling pathway | 1.20e-04 | 6 | 59 | 2 | GO:0070564 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 1.48e-04 | 36 | 59 | 3 | GO:0086010 | |
| GeneOntologyBiologicalProcess | retinoic acid receptor signaling pathway | 1.75e-04 | 38 | 59 | 3 | GO:0048384 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 2.98e-04 | 112 | 59 | 4 | GO:0019226 | |
| GeneOntologyBiologicalProcess | myelination | 3.06e-04 | 206 | 59 | 5 | GO:0042552 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 3.20e-04 | 208 | 59 | 5 | GO:0035725 | |
| GeneOntologyBiologicalProcess | axon ensheathment | 3.27e-04 | 209 | 59 | 5 | GO:0008366 | |
| GeneOntologyBiologicalProcess | ensheathment of neurons | 3.27e-04 | 209 | 59 | 5 | GO:0007272 | |
| GeneOntologyBiologicalProcess | regulation of vitamin D receptor signaling pathway | 3.57e-04 | 10 | 59 | 2 | GO:0070562 | |
| GeneOntologyBiologicalProcess | positive regulation of bone mineralization | 3.73e-04 | 49 | 59 | 3 | GO:0030501 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 3.88e-04 | 217 | 59 | 5 | GO:0006941 | |
| GeneOntologyBiologicalProcess | response to pain | 4.20e-04 | 51 | 59 | 3 | GO:0048265 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 1.41e-05 | 17 | 59 | 3 | GO:0001518 | |
| GeneOntologyCellularComponent | T-tubule | 7.34e-05 | 79 | 59 | 4 | GO:0030315 | |
| GeneOntologyCellularComponent | sodium channel complex | 7.41e-05 | 29 | 59 | 3 | GO:0034706 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 6.75e-04 | 378 | 59 | 6 | GO:0034702 | |
| GeneOntologyCellularComponent | acetylcholine-gated channel complex | 1.16e-03 | 18 | 59 | 2 | GO:0005892 | |
| GeneOntologyCellularComponent | node of Ranvier | 1.44e-03 | 20 | 59 | 2 | GO:0033268 | |
| MousePheno | suppressed circulating follicle stimulating hormone level | 3.46e-05 | 3 | 48 | 2 | MP:0001749 | |
| Domain | Retinoid-X_rcpt/HNF4 | 1.86e-08 | 10 | 59 | 4 | IPR000003 | |
| Domain | zf-C4 | 3.28e-07 | 46 | 59 | 5 | PF00105 | |
| Domain | Znf_hrmn_rcpt | 3.28e-07 | 46 | 59 | 5 | IPR001628 | |
| Domain | Nuclear_hrmn_rcpt | 3.28e-07 | 46 | 59 | 5 | IPR001723 | |
| Domain | NUCLEAR_REC_DBD_2 | 3.28e-07 | 46 | 59 | 5 | PS51030 | |
| Domain | NUCLEAR_REC_DBD_1 | 3.28e-07 | 46 | 59 | 5 | PS00031 | |
| Domain | ZnF_C4 | 3.28e-07 | 46 | 59 | 5 | SM00399 | |
| Domain | - | 3.67e-07 | 47 | 59 | 5 | 1.10.565.10 | |
| Domain | HOLI | 4.08e-07 | 48 | 59 | 5 | SM00430 | |
| Domain | Nucl_hrmn_rcpt_lig-bd | 4.08e-07 | 48 | 59 | 5 | IPR000536 | |
| Domain | Hormone_recep | 4.08e-07 | 48 | 59 | 5 | PF00104 | |
| Domain | Na_trans_cytopl | 5.95e-07 | 6 | 59 | 3 | PF11933 | |
| Domain | Na_trans_cytopl | 5.95e-07 | 6 | 59 | 3 | IPR024583 | |
| Domain | - | 9.77e-07 | 57 | 59 | 5 | 3.30.50.10 | |
| Domain | Znf_NHR/GATA | 1.07e-06 | 58 | 59 | 5 | IPR013088 | |
| Domain | Na_channel_asu | 3.54e-06 | 10 | 59 | 3 | IPR001696 | |
| Domain | Na_trans_assoc | 3.54e-06 | 10 | 59 | 3 | IPR010526 | |
| Domain | Na_trans_assoc | 3.54e-06 | 10 | 59 | 3 | PF06512 | |
| Domain | Uncharacterised_TMEM39 | 9.81e-06 | 2 | 59 | 2 | IPR019397 | |
| Domain | Nuc_recep-AF1 | 9.81e-06 | 2 | 59 | 2 | PF11825 | |
| Domain | Tmp39 | 9.81e-06 | 2 | 59 | 2 | PF10271 | |
| Domain | Nuc_recep-AF1 | 9.81e-06 | 2 | 59 | 2 | IPR021780 | |
| Domain | Channel_four-helix_dom | 3.13e-05 | 57 | 59 | 4 | IPR027359 | |
| Domain | - | 3.13e-05 | 57 | 59 | 4 | 1.20.120.350 | |
| Domain | IQ | 1.25e-04 | 81 | 59 | 4 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 1.87e-04 | 90 | 59 | 4 | IPR000048 | |
| Domain | IQ | 2.13e-04 | 93 | 59 | 4 | PS50096 | |
| Domain | Ion_trans_dom | 4.63e-04 | 114 | 59 | 4 | IPR005821 | |
| Domain | Ion_trans | 4.63e-04 | 114 | 59 | 4 | PF00520 | |
| Domain | Nicotinic_acetylcholine_rcpt | 1.14e-03 | 16 | 59 | 2 | IPR002394 | |
| Domain | DUF1605 | 1.29e-03 | 17 | 59 | 2 | IPR011709 | |
| Domain | OB_NTP_bind | 1.29e-03 | 17 | 59 | 2 | PF07717 | |
| Domain | HA2 | 1.45e-03 | 18 | 59 | 2 | SM00847 | |
| Domain | HA2 | 1.45e-03 | 18 | 59 | 2 | PF04408 | |
| Domain | Helicase-assoc_dom | 1.45e-03 | 18 | 59 | 2 | IPR007502 | |
| Domain | IQ | 1.47e-03 | 71 | 59 | 3 | PF00612 | |
| Domain | EF-hand-dom_pair | 2.10e-03 | 287 | 59 | 5 | IPR011992 | |
| Domain | - | 2.38e-03 | 23 | 59 | 2 | 1.20.120.370 | |
| Domain | Acetylcholine_rcpt_TM | 2.38e-03 | 23 | 59 | 2 | IPR027361 | |
| Domain | MARVEL | 3.27e-03 | 27 | 59 | 2 | PF01284 | |
| Domain | Marvel | 3.52e-03 | 28 | 59 | 2 | IPR008253 | |
| Domain | MARVEL | 3.52e-03 | 28 | 59 | 2 | PS51225 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 5.46e-03 | 35 | 59 | 2 | IPR002464 | |
| Domain | DEAH_ATP_HELICASE | 6.41e-03 | 38 | 59 | 2 | PS00690 | |
| Domain | Neurotransmitter_ion_chnl_CS | 8.90e-03 | 45 | 59 | 2 | IPR018000 | |
| Domain | Neur_chan_memb | 9.29e-03 | 46 | 59 | 2 | PF02932 | |
| Pathway | KEGG_MEDICUS_VARIANT_PAX8_PPARG_FUSION_TO_PPARG_MEDIATED_TRANSCRIPTION | 3.03e-07 | 5 | 45 | 3 | M49023 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 4.08e-07 | 48 | 45 | 5 | MM14987 | |
| Pathway | WP_VITAMIN_A1_AND_A5X_PATHWAYS | 6.04e-07 | 6 | 45 | 3 | M48097 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 6.75e-07 | 53 | 45 | 5 | M8276 | |
| Pathway | KEGG_THYROID_CANCER | 2.03e-06 | 29 | 45 | 4 | M523 | |
| Pathway | KEGG_MEDICUS_REFERENCE_THYROID_HORMONE_SIGNALING_PATHWAY | 2.52e-06 | 9 | 45 | 3 | M47629 | |
| Pathway | PID_AR_TF_PATHWAY | 2.37e-05 | 53 | 45 | 4 | M151 | |
| Pathway | KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY | 6.00e-05 | 67 | 45 | 4 | M10462 | |
| Pathway | PID_RXR_VDR_PATHWAY | 7.51e-05 | 26 | 45 | 3 | M162 | |
| Pathway | WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3 | 9.33e-05 | 75 | 45 | 4 | M39568 | |
| Pathway | WP_DRAVET_SYNDROME | 9.42e-05 | 28 | 45 | 3 | M45519 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_GLUCONEOGENESIS | 9.90e-05 | 5 | 45 | 2 | M29812 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_LIMIT_CHOLESTEROL_UPTAKE | 9.90e-05 | 5 | 45 | 2 | M29791 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_TRIGLYCERIDE_LIPOLYSIS_IN_ADIPOSE | 9.90e-05 | 5 | 45 | 2 | M29792 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 1.16e-04 | 30 | 45 | 3 | M207 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 1.28e-04 | 31 | 45 | 3 | M877 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 1.41e-04 | 32 | 45 | 3 | M27455 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS | 1.48e-04 | 6 | 45 | 2 | MM15663 | |
| Pathway | WP_NUCLEAR_RECEPTORS | 2.37e-04 | 38 | 45 | 3 | M39657 | |
| Pathway | WP_NUCLEAR_RECEPTORS | 2.37e-04 | 38 | 45 | 3 | MM15865 | |
| Pathway | WP_VITAMIN_A_AND_CAROTENOID_METABOLISM | 3.43e-04 | 43 | 45 | 3 | M39554 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 3.43e-04 | 43 | 45 | 3 | M27443 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS | 3.54e-04 | 9 | 45 | 2 | M29809 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_LIPOGENESIS | 3.54e-04 | 9 | 45 | 2 | M29789 | |
| Pathway | WP_RETINOL_METABOLISM | 3.67e-04 | 44 | 45 | 3 | MM15851 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 4.19e-04 | 46 | 45 | 3 | M239 | |
| Pathway | WP_VITAMIN_D_METABOLISM | 4.41e-04 | 10 | 45 | 2 | M39352 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 5.05e-04 | 49 | 45 | 3 | MM15186 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 5.33e-04 | 118 | 45 | 4 | M27316 | |
| Pathway | REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 6.44e-04 | 12 | 45 | 2 | M48008 | |
| Pathway | KEGG_NON_SMALL_CELL_LUNG_CANCER | 6.73e-04 | 54 | 45 | 3 | M19818 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 7.60e-04 | 13 | 45 | 2 | MM15622 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 7.68e-04 | 130 | 45 | 4 | M27454 | |
| Pathway | WP_ADIPOGENESIS | 7.90e-04 | 131 | 45 | 4 | M39505 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 8.85e-04 | 14 | 45 | 2 | M757 | |
| Pathway | WP_ADIPOGENESIS_GENES | 9.34e-04 | 137 | 45 | 4 | MM15970 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 1.02e-03 | 15 | 45 | 2 | MM14704 | |
| Pathway | WP_PPAR_SIGNALING | 1.26e-03 | 67 | 45 | 3 | M39553 | |
| Pathway | KEGG_PPAR_SIGNALING_PATHWAY | 1.37e-03 | 69 | 45 | 3 | M13088 | |
| Pathway | WP_NONSMALL_CELL_LUNG_CANCER | 1.55e-03 | 72 | 45 | 3 | M39738 | |
| Pathway | WP_PPAR_SIGNALING_PATHWAY | 1.62e-03 | 73 | 45 | 3 | MM15995 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 1.70e-03 | 161 | 45 | 4 | M27871 | |
| Pathway | WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS | 2.21e-03 | 22 | 45 | 2 | M39414 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 2.42e-03 | 84 | 45 | 3 | M1008 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 2.42e-03 | 84 | 45 | 3 | M3228 | |
| Pubmed | 4.88e-09 | 3 | 60 | 3 | 12610651 | ||
| Pubmed | 4.88e-09 | 3 | 60 | 3 | 7831303 | ||
| Pubmed | 4.88e-09 | 3 | 60 | 3 | 23859570 | ||
| Pubmed | Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. | 4.88e-09 | 3 | 60 | 3 | 1312497 | |
| Pubmed | 4.88e-09 | 3 | 60 | 3 | 18784617 | ||
| Pubmed | Detection of retinoid X receptors using specific monoclonal and polyclonal antibodies. | 4.88e-09 | 3 | 60 | 3 | 7980510 | |
| Pubmed | 4.88e-09 | 3 | 60 | 3 | 17544618 | ||
| Pubmed | Immunohistochemical detection of the retinoid X receptors alpha, beta, and gamma in human prostate. | 4.88e-09 | 3 | 60 | 3 | 12514092 | |
| Pubmed | 4.88e-09 | 3 | 60 | 3 | 11053444 | ||
| Pubmed | Retinoid X receptors: X-ploring their (patho)physiological functions. | 4.88e-09 | 3 | 60 | 3 | 15608692 | |
| Pubmed | 4.88e-09 | 3 | 60 | 3 | 8034312 | ||
| Pubmed | Retinoid receptors trigger neuritogenesis in retinal degenerations. | 4.88e-09 | 3 | 60 | 3 | 21940995 | |
| Pubmed | 4.88e-09 | 3 | 60 | 3 | 11839661 | ||
| Pubmed | 4.88e-09 | 3 | 60 | 3 | 14973256 | ||
| Pubmed | 4.88e-09 | 3 | 60 | 3 | 8799145 | ||
| Pubmed | 7.91e-09 | 14 | 60 | 4 | 18561907 | ||
| Pubmed | Confirmation of quantitative trait loci for alcohol preference in mice. | 1.08e-08 | 15 | 60 | 4 | 9726281 | |
| Pubmed | 1.95e-08 | 4 | 60 | 3 | 17537961 | ||
| Pubmed | 1.95e-08 | 4 | 60 | 3 | 35031483 | ||
| Pubmed | 1.95e-08 | 4 | 60 | 3 | 1310259 | ||
| Pubmed | 1.95e-08 | 4 | 60 | 3 | 29578003 | ||
| Pubmed | Retinoic acid biosynthetic activity and retinoid receptors in the olfactory mucosa of adult mice. | 1.95e-08 | 4 | 60 | 3 | 10079186 | |
| Pubmed | 1.95e-08 | 4 | 60 | 3 | 26355550 | ||
| Pubmed | Retinoids activate RXR/CAR-mediated pathway and induce CYP3A. | 1.95e-08 | 4 | 60 | 3 | 19686701 | |
| Pubmed | 1.95e-08 | 4 | 60 | 3 | 9804293 | ||
| Pubmed | 1.95e-08 | 4 | 60 | 3 | 10611353 | ||
| Pubmed | 1.95e-08 | 4 | 60 | 3 | 35801810 | ||
| Pubmed | Use of recombinant inbred strains for studying genetic determinants of responses to alcohol. | 1.95e-08 | 4 | 60 | 3 | 8974318 | |
| Pubmed | 4.87e-08 | 5 | 60 | 3 | 1679748 | ||
| Pubmed | 4.87e-08 | 5 | 60 | 3 | 8812438 | ||
| Pubmed | Developmental expression of murine retinoid X receptor (RXR) genes. | 4.87e-08 | 5 | 60 | 3 | 8199055 | |
| Pubmed | Retinoic acid signaling is necessary for the development of the organ of Corti. | 4.87e-08 | 5 | 60 | 3 | 10452855 | |
| Pubmed | 4.87e-08 | 5 | 60 | 3 | 24337656 | ||
| Pubmed | Systematic immunolocalization of retinoid receptors in developing and adult mouse eyes. | 9.73e-08 | 6 | 60 | 3 | 11328745 | |
| Pubmed | 9.73e-08 | 6 | 60 | 3 | 9153406 | ||
| Pubmed | Spatial distributions of retinoic acid receptor gene transcripts in the prenatal mouse inner ear. | 9.73e-08 | 6 | 60 | 3 | 9548551 | |
| Pubmed | Functional specificity of the two retinoic acid receptor RAR and RXR families in myogenesis. | 9.73e-08 | 6 | 60 | 3 | 9464546 | |
| Pubmed | Inflammatory chemokine release of astrocytes in vitro is reduced by all-trans retinoic acid. | 9.73e-08 | 6 | 60 | 3 | 20557428 | |
| Pubmed | 9.73e-08 | 6 | 60 | 3 | 8801169 | ||
| Pubmed | 9.73e-08 | 6 | 60 | 3 | 8801176 | ||
| Pubmed | 9.73e-08 | 6 | 60 | 3 | 22205725 | ||
| Pubmed | The RXRalpha ligand-dependent activation function 2 (AF-2) is important for mouse development. | 9.73e-08 | 6 | 60 | 3 | 9806918 | |
| Pubmed | 9.73e-08 | 6 | 60 | 3 | 16428452 | ||
| Pubmed | A genetic dissection of the retinoid signalling pathway in the mouse. | 9.73e-08 | 6 | 60 | 3 | 10604193 | |
| Pubmed | 9.73e-08 | 6 | 60 | 3 | 7947324 | ||
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 9.73e-08 | 6 | 60 | 3 | 23652591 | |
| Pubmed | 9.73e-08 | 6 | 60 | 3 | 9075714 | ||
| Pubmed | 1.70e-07 | 7 | 60 | 3 | 9428411 | ||
| Pubmed | Differential contributions of AF-1 and AF-2 activities to the developmental functions of RXR alpha. | 1.70e-07 | 7 | 60 | 3 | 11493527 | |
| Pubmed | 1.70e-07 | 7 | 60 | 3 | 12360493 | ||
| Pubmed | 1.70e-07 | 7 | 60 | 3 | 17195188 | ||
| Pubmed | 1.70e-07 | 7 | 60 | 3 | 10406480 | ||
| Pubmed | 1.70e-07 | 7 | 60 | 3 | 8299717 | ||
| Pubmed | 1.70e-07 | 7 | 60 | 3 | 15635645 | ||
| Pubmed | 1.70e-07 | 7 | 60 | 3 | 8090775 | ||
| Pubmed | 2.72e-07 | 8 | 60 | 3 | 10490294 | ||
| Pubmed | Expression of nuclear retinoic acid receptors during mouse odontogenesis. | 2.72e-07 | 8 | 60 | 3 | 7988794 | |
| Pubmed | Retinoids and adipose tissues: metabolism, cell differentiation and gene expression. | 2.72e-07 | 8 | 60 | 3 | 10094571 | |
| Pubmed | 2.72e-07 | 8 | 60 | 3 | 16043864 | ||
| Pubmed | Prepubertal testis development relies on retinoic acid but not rexinoid receptors in Sertoli cells. | 2.72e-07 | 8 | 60 | 3 | 17124491 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SCAP MARVELD1 MROH6 ZMIZ2 NUP188 PIGG LTBP4 ABCA7 MED12 RASAL1 DHX30 TPCN1 | 3.42e-07 | 1105 | 60 | 12 | 35748872 |
| Pubmed | 4.07e-07 | 9 | 60 | 3 | 16382098 | ||
| Pubmed | 4.07e-07 | 9 | 60 | 3 | 15746173 | ||
| Pubmed | 4.07e-07 | 9 | 60 | 3 | 7823919 | ||
| Pubmed | Enhancer activation requires trans-recruitment of a mega transcription factor complex. | 5.81e-07 | 10 | 60 | 3 | 25303530 | |
| Pubmed | 7.97e-07 | 11 | 60 | 3 | 29093497 | ||
| Pubmed | 1.06e-06 | 12 | 60 | 3 | 15589691 | ||
| Pubmed | 1.06e-06 | 12 | 60 | 3 | 8169823 | ||
| Pubmed | 1.06e-06 | 12 | 60 | 3 | 9022057 | ||
| Pubmed | Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice. | 1.06e-06 | 12 | 60 | 3 | 30175250 | |
| Pubmed | 1.06e-06 | 12 | 60 | 3 | 26427057 | ||
| Pubmed | 1.38e-06 | 13 | 60 | 3 | 15123669 | ||
| Pubmed | 1.38e-06 | 13 | 60 | 3 | 1358808 | ||
| Pubmed | 1.75e-06 | 14 | 60 | 3 | 18393306 | ||
| Pubmed | 1.75e-06 | 14 | 60 | 3 | 21923909 | ||
| Pubmed | 1.94e-06 | 118 | 60 | 5 | 16971476 | ||
| Pubmed | 2.19e-06 | 15 | 60 | 3 | 19448158 | ||
| Pubmed | 2.69e-06 | 16 | 60 | 3 | 25577283 | ||
| Pubmed | 2.69e-06 | 16 | 60 | 3 | 11795391 | ||
| Pubmed | RXR alpha mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis. | 2.93e-06 | 2 | 60 | 2 | 7926783 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 29649454 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 20346423 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 22020178 | ||
| Pubmed | Thyroid hormone resistance and increased metabolic rate in the RXR-gamma-deficient mouse. | 2.93e-06 | 2 | 60 | 2 | 10880050 | |
| Pubmed | Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice. | 2.93e-06 | 2 | 60 | 2 | 10827969 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 19694741 | ||
| Pubmed | Genomic structures of SCN2A and SCN3A - candidate genes for deafness at the DFNA16 locus. | 2.93e-06 | 2 | 60 | 2 | 11245985 | |
| Pubmed | Differential expression of two sodium channel subtypes in human brain. | 2.93e-06 | 2 | 60 | 2 | 1317301 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 24810760 | ||
| Pubmed | Duplication of the sodium channel gene cluster on 2q24 in children with early onset epilepsy. | 2.93e-06 | 2 | 60 | 2 | 23016767 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 8780715 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 27153334 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 33096315 | ||
| Pubmed | Electrophysiological Differences between the Same Pore Region Mutation in SCN1A and SCN3A. | 2.93e-06 | 2 | 60 | 2 | 24990319 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 20798333 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 22316320 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 31439038 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 33246082 | ||
| Pubmed | Endogenous retinoid X receptor ligands in mouse hematopoietic cells. | 2.93e-06 | 2 | 60 | 2 | 29089448 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 26311622 | ||
| Interaction | NR2E3 interactions | 4.09e-07 | 21 | 60 | 4 | int:NR2E3 | |
| Interaction | HTR3A interactions | 1.74e-05 | 108 | 60 | 5 | int:HTR3A | |
| Interaction | B4GAT1 interactions | 1.90e-05 | 110 | 60 | 5 | int:B4GAT1 | |
| Interaction | BMPR1A interactions | 3.26e-05 | 205 | 60 | 6 | int:BMPR1A | |
| Interaction | VDR interactions | 3.80e-05 | 127 | 60 | 5 | int:VDR | |
| Cytoband | 2q24.3 | 1.99e-04 | 16 | 60 | 2 | 2q24.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q24 | 6.30e-04 | 127 | 60 | 3 | chr2q24 | |
| GeneFamily | Nuclear hormone receptors | 1.67e-07 | 49 | 47 | 5 | 71 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 1.37e-06 | 9 | 47 | 3 | 1203 | |
| GeneFamily | Cholinergic receptors nicotinic subunits | 7.75e-04 | 16 | 47 | 2 | 173 | |
| GeneFamily | DEAH-box helicases | 7.75e-04 | 16 | 47 | 2 | 500 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.57e-06 | 161 | 60 | 5 | ba7ce599b173cf81c8323e7c96dc3d57379f1ed6 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-06 | 170 | 60 | 5 | b4f2c05db2c2591561fd42febc72eed3b5e8f9fb | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-D_(AT2)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 7.04e-06 | 198 | 60 | 5 | 963b7ff8c5322d9290bbaf42137bb8fdd0672db9 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.16e-05 | 143 | 60 | 4 | 5fb5a4ea93e5cce55d427e3b4a50a979504fad3c | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_immature_3|E16.5-samps / Age Group, Lineage, Cell class and subclass | 4.88e-05 | 149 | 60 | 4 | 651494e84be03dc7b061ebdfa91756a1c507b9b4 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-H-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.14e-05 | 151 | 60 | 4 | 2dc132895609e4efe17954e31f53d9c1ccf256ef | |
| ToppCell | 356C-Fibroblasts-Fibroblast-H|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.14e-05 | 151 | 60 | 4 | 22afd8201eff8471da3456be065f2790de5e4bfe | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.69e-05 | 155 | 60 | 4 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | frontal_cortex-Non-neuronal-smooth_muscle_cell|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.13e-05 | 158 | 60 | 4 | 08806240228c5b780f5aef92ce2c278ae4d797cc | |
| ToppCell | frontal_cortex-Non-neuronal-smooth_muscle_cell-SMC-SMC_Acta2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.13e-05 | 158 | 60 | 4 | 496b6988f7b3439968351840ae22f56ffa1643f1 | |
| ToppCell | frontal_cortex-Non-neuronal-smooth_muscle_cell-SMC|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.13e-05 | 158 | 60 | 4 | 5b3d30f92b619f14a7b48502170000fa5783358a | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 6.28e-05 | 159 | 60 | 4 | 655c0749c238bd68cb797adb83e25a23b8a3cc9d | |
| ToppCell | VE-CD8-CD4_Treg|VE / Condition, Cell_class and T cell subcluster | 6.59e-05 | 161 | 60 | 4 | a114f4f75859d9ef900e5146686438d051241429 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.59e-05 | 167 | 60 | 4 | 7f3224af9b30082b927a822b91f96e0c88151b4e | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.59e-05 | 167 | 60 | 4 | a21a2b301d0a3d7a41e605f7a3c37548962a331d | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.59e-05 | 167 | 60 | 4 | 0e746483773bde6582874a33591ab2a578d724eb | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-stromal_related|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.77e-05 | 168 | 60 | 4 | e40a3f85be7e9bb23bfbc1f9cb5e5fc54bb43863 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.77e-05 | 168 | 60 | 4 | b1d6c35a5ae69c8638afd68c2be5bc9ce6fd2659 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.51e-05 | 177 | 60 | 4 | 1dc69c661e70e7e22bd9d7cf953eb638da9fd43c | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.51e-05 | 177 | 60 | 4 | 426a9845df7fd13b02e744532c336c60bc4d4a22 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Myeloid-macrophage|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.72e-05 | 178 | 60 | 4 | 6c1b5087581ca8cea976d89ea6f34088c8fc3668 | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_postreplicative-neuro_neuronal_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.93e-05 | 179 | 60 | 4 | af0b54c9ea0b6e4210f22dbb6e88ecd3276a5f86 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.04e-04 | 181 | 60 | 4 | 58f76bb9ea1518c2b629a0256a3f6595a9278152 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.10e-04 | 184 | 60 | 4 | 25ccf08a8a26d7e7827b6357f33a53aaf423577d | |
| ToppCell | Caecum-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 1.16e-04 | 70 | 60 | 3 | 05f8fc648641b9db50c2ae20d6246b52869957cf | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 187 | 60 | 4 | 51f1c6bac3abae1d20aa8ac46642bcdbc02cb0a2 | |
| ToppCell | droplet-Lung-immune-endo-depleted|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 189 | 60 | 4 | c3fb363bb0156ffb3367c200f548faebda64ab4a | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 189 | 60 | 4 | 2a2953f6b1b7d070d739dcaf7285fce6e097d9e4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-04 | 189 | 60 | 4 | 532aaf02b364c5c4f58a2021c7c21d86df3875c9 | |
| ToppCell | droplet-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.22e-04 | 189 | 60 | 4 | 5a636e952da9b1fd26aa17f7b129054f2da322b5 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 190 | 60 | 4 | 9cd147a174017ebda23cc47b6d4552d898acd092 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.27e-04 | 191 | 60 | 4 | 44a9a6768084dafc641ad455b65862bfd4cc0cb9 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 191 | 60 | 4 | a261f0738d974784bbdd60f23092bfbcca464459 | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 191 | 60 | 4 | 5c1f5b6c115b1b27b4a7467a6550ce43c01cf6d0 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 191 | 60 | 4 | 6594398cc8151c73696391a43ac110c10283dab1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-04 | 191 | 60 | 4 | 96b78b4e819ea6052334bfcbc7abbf35897df885 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 191 | 60 | 4 | b9ae5af426e7a1f2652a47700bb168371bd2dec6 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-04 | 192 | 60 | 4 | 0bb06738e1c3ec0c044a7ee61f6cf1d4781fb53c | |
| ToppCell | 368C-Endothelial_cells-Endothelial-B_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.30e-04 | 192 | 60 | 4 | aedddccacf60e884af044cefba6c64ca10ac97d2 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-B_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.30e-04 | 192 | 60 | 4 | 389d5e6d0689371bfe1d0b06e92e0e6e5573567b | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 192 | 60 | 4 | eb9a0b3d32f90f8b95905c740aab21639dae5cbd | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Squamous|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.30e-04 | 192 | 60 | 4 | 103496f428f59683ac3ae6147682c07c30663724 | |
| ToppCell | droplet-Lung-nan-21m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 192 | 60 | 4 | e429e8fbc48ad26204a0197b9129e58be56bd7b6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-04 | 194 | 60 | 4 | 46070fbb0ee0eb9e1801c43b73a15707471056dc | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-04 | 194 | 60 | 4 | abacb6a8d7a9003f2f6c2be0305507f1c1c50347 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.38e-04 | 195 | 60 | 4 | 787e95fb59c40bba784544b662fac37606ae1427 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.41e-04 | 196 | 60 | 4 | eb7d6bbfb766cdeaf5fe0f0bb66a5f491fd5ef26 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-04 | 196 | 60 | 4 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-E_(AT2)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.46e-04 | 198 | 60 | 4 | 498f11441c0a0982738537bcfcfc2877866b7400 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.46e-04 | 198 | 60 | 4 | d6812494874be0c14361ac2ac3e418b335bb8f55 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Smooth_muscle-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.49e-04 | 199 | 60 | 4 | 2c5ad62919c64ea0242e0984bb9932d2d975f4e3 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.52e-04 | 200 | 60 | 4 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.52e-04 | 200 | 60 | 4 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.52e-04 | 200 | 60 | 4 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.52e-04 | 200 | 60 | 4 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.52e-04 | 200 | 60 | 4 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.52e-04 | 200 | 60 | 4 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| Drug | Bexarotene | 1.74e-08 | 3 | 60 | 3 | DB00307 | |
| Drug | 2-hydroxyphytanic acid | 1.74e-08 | 3 | 60 | 3 | ctd:C002585 | |
| Drug | AC1O5SBP | 1.74e-08 | 3 | 60 | 3 | CID006439746 | |
| Drug | AGN 190727 | 6.95e-08 | 4 | 60 | 3 | CID006439768 | |
| Drug | 7-methoxycitronellal | 1.73e-07 | 5 | 60 | 3 | CID000019223 | |
| Drug | 7-methoxycitronellic acid | 1.73e-07 | 5 | 60 | 3 | CID000171516 | |
| Drug | 13,14-dihydroretinol | 1.73e-07 | 5 | 60 | 3 | CID000446798 | |
| Drug | Alitretinoin | 3.46e-07 | 6 | 60 | 3 | DB00523 | |
| Drug | Adapalene | 3.46e-07 | 6 | 60 | 3 | DB00210 | |
| Drug | triphenyltin hydroxide | 3.46e-07 | 6 | 60 | 3 | ctd:C007567 | |
| Drug | Etretinate | 3.46e-07 | 6 | 60 | 3 | DB00926 | |
| Drug | Acitretin | 6.04e-07 | 7 | 60 | 3 | DB00459 | |
| Drug | AGN 191659 | 6.04e-07 | 7 | 60 | 3 | CID006366726 | |
| Drug | AGN 190121 | 6.04e-07 | 7 | 60 | 3 | CID006441236 | |
| Drug | Prt-H | 6.24e-07 | 26 | 60 | 4 | CID003050291 | |
| Drug | Nitrarine dihydrochloride [20069-05-0]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 8.55e-07 | 197 | 60 | 7 | 6043_UP | |
| Drug | HX 600 | 9.65e-07 | 8 | 60 | 3 | ctd:C104181 | |
| Drug | TTNN | 9.65e-07 | 8 | 60 | 3 | CID000135754 | |
| Drug | Tretinoin | 9.65e-07 | 8 | 60 | 3 | DB00755 | |
| Drug | AC1O5JP6 | 9.65e-07 | 8 | 60 | 3 | CID006435379 | |
| Drug | SR-12813 | 9.85e-07 | 29 | 60 | 4 | CID000446313 | |
| Drug | HX 630 | 2.06e-06 | 10 | 60 | 3 | ctd:C422175 | |
| Drug | diazepinylbenzoic acid | 2.06e-06 | 10 | 60 | 3 | ctd:C438269 | |
| Drug | AGN 191701 | 2.83e-06 | 11 | 60 | 3 | CID006438168 | |
| Drug | UVI 3003 | 2.83e-06 | 11 | 60 | 3 | ctd:C525131 | |
| Drug | Musk T | 2.83e-06 | 11 | 60 | 3 | CID000061014 | |
| Drug | di-n-propylphthalate | 3.76e-06 | 12 | 60 | 3 | ctd:C106479 | |
| Drug | NSC46155 | 3.76e-06 | 12 | 60 | 3 | CID000457869 | |
| Drug | tazarotenic acid | 4.88e-06 | 13 | 60 | 3 | CID000147525 | |
| Drug | GW2331 | 4.88e-06 | 13 | 60 | 3 | CID000657048 | |
| Drug | Cd2665 | 4.88e-06 | 13 | 60 | 3 | CID000216241 | |
| Drug | AC1L1DMQ | 6.20e-06 | 14 | 60 | 3 | CID000002418 | |
| Drug | Sulfonamides | 6.20e-06 | 14 | 60 | 3 | ctd:D013449 | |
| Drug | phthalic acid | 1.15e-05 | 17 | 60 | 3 | ctd:C032279 | |
| Drug | Zonisamide | 1.15e-05 | 17 | 60 | 3 | DB00909 | |
| Drug | Alverine citrate salt [5560-59-8]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 1.36e-05 | 198 | 60 | 6 | 2273_UP | |
| Drug | Triflusal [322-79-2]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 1.36e-05 | 198 | 60 | 6 | 7451_UP | |
| Drug | HX600 | 1.38e-05 | 18 | 60 | 3 | CID000128016 | |
| Drug | androst-2-en-3-ol | 1.38e-05 | 18 | 60 | 3 | CID000166036 | |
| Drug | diheptyl phthalate | 2.24e-05 | 21 | 60 | 3 | ctd:C089799 | |
| Drug | di-n-hexyl phthalate | 2.59e-05 | 22 | 60 | 3 | ctd:C027387 | |
| Drug | adapalene | 2.59e-05 | 22 | 60 | 3 | CID000060164 | |
| Drug | Ro 15-0778 | 2.97e-05 | 23 | 60 | 3 | CID006436116 | |
| Drug | DITPA | 3.39e-05 | 24 | 60 | 3 | CID000160565 | |
| Drug | ponasterone A | 3.51e-05 | 70 | 60 | 4 | CID000115127 | |
| Drug | scoparone | 3.84e-05 | 25 | 60 | 3 | CID000008417 | |
| Drug | AC1L2X6Z | 4.86e-05 | 27 | 60 | 3 | CID000130325 | |
| Drug | mono-(2-ethylhexyl)phthalate | 5.28e-05 | 658 | 60 | 9 | ctd:C016599 | |
| Drug | A-74702 | 5.93e-05 | 80 | 60 | 4 | CID000452307 | |
| Drug | AGN 193109 | 7.42e-05 | 31 | 60 | 3 | CID000177238 | |
| Drug | T0070907 | 7.42e-05 | 31 | 60 | 3 | CID002777391 | |
| Drug | tamibarotene | 7.87e-05 | 86 | 60 | 4 | CID000108143 | |
| Drug | ciglitazone | 8.34e-05 | 169 | 60 | 5 | CID000002750 | |
| Drug | CD367 | 8.97e-05 | 33 | 60 | 3 | CID000119342 | |
| Drug | AC1L3LFV | 8.97e-05 | 33 | 60 | 3 | CID000091134 | |
| Drug | Retinoids | 9.82e-05 | 34 | 60 | 3 | ctd:D012176 | |
| Drug | APETx1, Anthopleura elegantissima | 1.02e-04 | 6 | 60 | 2 | ctd:C475726 | |
| Drug | fenpropathrin | 1.02e-04 | 6 | 60 | 2 | ctd:C044267 | |
| Drug | Methoprene | 1.02e-04 | 6 | 60 | 2 | ctd:D008726 | |
| Drug | DR-0 | 1.07e-04 | 35 | 60 | 3 | CID010062716 | |
| Drug | Ro 41-5253 | 1.27e-04 | 37 | 60 | 3 | CID005312120 | |
| Drug | Ivermectin [70288-86-7]; Up 200; 4.6uM; MCF7; HT_HG-U133A | 1.41e-04 | 189 | 60 | 5 | 7206_UP | |
| Drug | 16-phenyl tetranor Prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A | 1.45e-04 | 190 | 60 | 5 | 7546_UP | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.52e-04 | 192 | 60 | 5 | 6958_UP | |
| Drug | Yohimbinic acid monohydrate [27801-27-2]; Up 200; 11.2uM; PC3; HT_HG-U133A | 1.59e-04 | 194 | 60 | 5 | 4082_UP | |
| Drug | tazarotene | 1.60e-04 | 40 | 60 | 3 | CID000005381 | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A | 1.67e-04 | 196 | 60 | 5 | 5569_DN | |
| Drug | Flecainide acetate [54143-56-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 1.71e-04 | 197 | 60 | 5 | 3937_DN | |
| Drug | Azathymine, 6 [932-53-6]; Up 200; 31.4uM; HL60; HT_HG-U133A | 1.71e-04 | 197 | 60 | 5 | 2466_UP | |
| Drug | vitamin D3 analog | 1.73e-04 | 41 | 60 | 3 | CID006438384 | |
| Drug | acyclic retinoid | 1.73e-04 | 41 | 60 | 3 | CID006437836 | |
| Drug | CP-944629 [668990-94-1]; Up 200; 10uM; PC3; HT_HG-U133A | 1.75e-04 | 198 | 60 | 5 | 7549_UP | |
| Drug | Lymecycline [992-21-2]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 1.79e-04 | 199 | 60 | 5 | 5994_UP | |
| Drug | 5-aza-2′-deoxycytidine; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.79e-04 | 199 | 60 | 5 | 920_DN | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Up 200; 7.2uM; PC3; HT_HG-U133A | 1.84e-04 | 200 | 60 | 5 | 3714_UP | |
| Drug | Cefadroxil [50370-12-2]; Up 200; 11uM; PC3; HT_HG-U133A | 1.84e-04 | 200 | 60 | 5 | 4080_UP | |
| Drug | rutamarin | 1.89e-04 | 8 | 60 | 2 | ctd:C022850 | |
| Drug | 2,3,5,6-tetrafluoro-4-methylbenzyl (Z)-(1RS)-cis-3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate | 1.89e-04 | 8 | 60 | 2 | ctd:C489827 | |
| Drug | tris | 2.25e-04 | 209 | 60 | 5 | CID000006503 | |
| Drug | AC1L3UEY | 2.26e-04 | 113 | 60 | 4 | CID000122342 | |
| Drug | AC1L1HRY | 2.28e-04 | 45 | 60 | 3 | CID000004265 | |
| Drug | Etretinate-d3 | 2.28e-04 | 45 | 60 | 3 | CID000003312 | |
| Drug | pozanicline | 2.43e-04 | 9 | 60 | 2 | ctd:C108326 | |
| Drug | S-(+)-Methoprene | 2.44e-04 | 46 | 60 | 3 | CID000038532 | |
| Drug | diethyl phthalate | 2.77e-04 | 48 | 60 | 3 | ctd:C007379 | |
| Drug | benzoate | 2.91e-04 | 221 | 60 | 5 | CID000000242 | |
| Drug | LG 268 | 3.03e-04 | 10 | 60 | 2 | ctd:C423914 | |
| Drug | di-n-pentyl phthalate | 3.31e-04 | 51 | 60 | 3 | ctd:C034171 | |
| Drug | Bezafibrate | 3.43e-04 | 229 | 60 | 5 | ctd:D001629 | |
| Drug | H type 2 | 3.86e-04 | 130 | 60 | 4 | CID005288910 | |
| Drug | AC1L1JB6 | 3.98e-04 | 131 | 60 | 4 | CID000004961 | |
| Drug | nilic acid | 4.43e-04 | 12 | 60 | 2 | CID000160471 | |
| Drug | benfluorex | 4.84e-04 | 58 | 60 | 3 | CID000002318 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 8.56e-07 | 10 | 58 | 3 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 8.56e-07 | 10 | 58 | 3 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.57e-06 | 12 | 58 | 3 | DOID:0060170 (implicated_via_orthology) | |
| Disease | anxiety disorder (implicated_via_orthology) | 1.08e-05 | 22 | 58 | 3 | DOID:2030 (implicated_via_orthology) | |
| Disease | cigarettes per day measurement | 2.37e-05 | 438 | 58 | 7 | EFO_0006525 | |
| Disease | HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 | 5.67e-05 | 6 | 58 | 2 | C3888239 | |
| Disease | Seizure, Febrile, Simple | 7.92e-05 | 7 | 58 | 2 | C0149886 | |
| Disease | Seizure, Febrile, Complex | 7.92e-05 | 7 | 58 | 2 | C0751057 | |
| Disease | alcohol dependence, risky sexual behaviour measurement | 1.06e-04 | 8 | 58 | 2 | EFO_0007877, MONDO_0007079 | |
| Disease | Febrile Convulsions | 1.35e-04 | 9 | 58 | 2 | C0009952 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 1.35e-04 | 9 | 58 | 2 | C3502809 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 2.92e-04 | 13 | 58 | 2 | C0751122 | |
| Disease | MMR-related febrile seizures | 3.92e-04 | 15 | 58 | 2 | EFO_0006519 | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 4.48e-04 | 16 | 58 | 2 | C0393706 | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 5.69e-04 | 18 | 58 | 2 | HP_0002373 | |
| Disease | Neurodevelopmental Disorders | 8.25e-04 | 93 | 58 | 3 | C1535926 | |
| Disease | Hirschsprung Disease | 1.70e-03 | 31 | 58 | 2 | C0019569 | |
| Disease | attention deficit hyperactivity disorder, bipolar disorder | 1.70e-03 | 31 | 58 | 2 | EFO_0003888, MONDO_0004985 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LIKDLGLRPKRTLRL | 316 | Q9Y646 | |
| RGVRKVFLRLLPQLL | 341 | P07510 | |
| LLGLKPLQLLEVKAR | 186 | P27037 | |
| LLILLKGLQRLNPAL | 571 | Q7L2E3 | |
| RLLWRRLKPLILGKL | 281 | Q8IZY2 | |
| LLLALVLAPRVLRAK | 16 | Q15293 | |
| RQLLLGRDQLRLKLL | 731 | O95294 | |
| KLVRGRKPLSLLVIL | 121 | Q8NFJ5 | |
| VRFGKLLLLLPSLRF | 366 | Q9Y5X4 | |
| KLERERPLSLLQLLG | 266 | P14672 | |
| LVELKRQALRLLLPG | 136 | Q2KJY2 | |
| NLLAKQGLRLLRGLR | 616 | A9Z1Z3 | |
| LRTLGLRSNRLKLIP | 121 | Q96FE5 | |
| ELLKLLLPLLLRYSG | 271 | Q93074 | |
| PLRALLLLKALQGLR | 421 | P03971 | |
| LRLGLRGPLRKLVLQ | 516 | A6NGR9 | |
| TFLLQGLLRLLKAPA | 21 | P49411 | |
| RDSLLKVLPALRILN | 1126 | Q96JM4 | |
| LLGALPLRSLTRQLV | 46 | Q8WUK0 | |
| LLRALRALVLKNRPL | 566 | P20393 | |
| LGLKLLLLLLLLPLR | 11 | P02747 | |
| SGPRALRLLLLVQLV | 6 | P30532 | |
| RLALLLLLVLGTPKS | 16 | P31415 | |
| QLRLVKALLLLGLNP | 6 | P34998 | |
| FLRSPLGVLRLLQLL | 26 | Q9BSK0 | |
| LITLLLRQNPLERLG | 816 | O15021 | |
| TSGRRPLLLVLLLPL | 6 | Q8N2S1 | |
| FTPKLLLVRKRLLGL | 711 | Q5W0V3 | |
| LRLRLLLSALKPGIH | 11 | Q86WA6 | |
| QKLLKRLRLLPALLI | 11 | O95661 | |
| RLRLLPALLILRAFK | 16 | O95661 | |
| IVTLRAKRNLPLKLL | 391 | Q8IY37 | |
| TDLLPGLRKLRNLLP | 151 | Q12770 | |
| AKLLLRLPALRSIGL | 416 | P19793 | |
| LKLINRPILVLRGLD | 376 | O14926 | |
| RPSLRLLSEKILGLQ | 361 | Q9GZR2 | |
| LGRLTTLIELLLPKL | 221 | P52630 | |
| RAVGERLLLKLQRLP | 11 | Q71RC9 | |
| LIILRNALDLLLPKL | 121 | P30566 | |
| SLLIGLLGPRLLQKV | 506 | Q86UD5 | |
| ILRLIKGAKGIRTLL | 1631 | Q9NY46 | |
| KLSRKQLVLRRGLLL | 536 | Q96FL8 | |
| ILRLIKGAKGIRTLL | 1646 | P35498 | |
| FAKLLLRLPALRSIG | 486 | P28702 | |
| IRLGLDPKLLAKILN | 231 | P31937 | |
| LLRRVLKGLQLLLSL | 36 | Q9NX76 | |
| RPLRLLNLLILIEGS | 416 | Q9NV64 | |
| ILRLIKGAKGIRTLL | 1636 | Q99250 | |
| ALPRLAIQLLKRLAT | 866 | Q5SRE5 | |
| FAKLLLRLPALRSIG | 416 | P48443 | |
| QQRGLILPVRTLLLK | 511 | Q9NXF1 | |
| LRLLLLLLLPLLGKV | 11 | P07949 | |
| VRSVLQGLLKKRLLP | 546 | Q8NF64 | |
| VVLRPLQLLRLFKLK | 536 | Q9ULQ1 | |
| ALLLALLLARAGLRK | 6 | Q9Y6M0 | |
| LGRLKLVLLELNFLP | 116 | P48556 | |
| LTLLLLSVPQALRRK | 446 | Q5H8A4 | |
| KRPLTLLQRAGLLLL | 256 | O95159 | |
| LLLLLLSLPPRARAK | 16 | Q8NBT3 | |
| SKPLRILNILLLLEG | 416 | Q9GZU3 | |
| LLKLPRTLILLLGGA | 36 | Q9UHF3 |